An additional limitation of viral gene-addition approaches in IPEX syndrome is that they cannot be applied to HSCs due to the toxicity of FOXP3 on HSCs in terms of stem cell proliferation and differentiation. This evidence concerns the gene FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.